1. Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment.
- Subjects
- Bile Duct Neoplasms pathology, Chemoradiotherapy, Combined Modality Therapy, Humans, Immunotherapy, Italy, Liver Transplantation, Patient Selection, Radiotherapy, Adjuvant, Surgical Procedures, Operative, Bile Duct Neoplasms therapy, Bile Ducts, Intrahepatic pathology, Cholangiocarcinoma therapy
- Abstract
Currently, the only curative treatment for cholangiocarcinoma (CCA) is surgical resection, though this treatment is possible in less than 40% of patients. However, recent improvements in preoperative management have led to a higher number of patients who are candidates for this procedure. For unresectable patients, progress is ongoing in terms of locoregional and chemoradiation treatments and target therapies, especially in the definition of patient selection criteria. This is the second part of the Italian CCA guidelines, dealing with CCA treatment, that have been formulated in accordance with Italian National Institute of Health indications and developed according to the GRADE method and related advancements., Competing Interests: Declaration of Competing Interest None., (Copyright © 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF